Advanced healthcare materials | 2023 | Locke RC, Zlotnick HM, Stoeckl BD, Fryhofer GW
Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.
[Indexed for MEDLINE] Conflict of interest statement: Declaration of interests The authors declare no conflicts of interest. 19. Nanomedicine (Lond). 2006 Aug;1(2):169-76. doi: 10.2217/17435889.1.2.169. Nanotechnology and biomaterials for orthopedic medical applications. Balasundaram G(1), Webster TJ. Author information: (1)Division of Engineering, Brown University, Providence, RI 02912, USA. gbala@brown.edu Future prospects for nanotechnology and biomaterials in medical applications appear to be excellent. In orthopedic applications, there is a significant need and demand for the development of a bone substitute that is bioactive and exhibits material properties (mechanical and surface) comparable with those of natural, healthy bone. Particularly, in bone tissue engineering, nanometer-sized ceramics, polymers, metals and composites have been receiving much attention recently. This is a result of current conventional materials (or those materials with constituent dimensions >1 microm) that have not invoked suitable cellular responses to promote adequate osteointegration to enable these devices to be successful for long periods. By contrast, owing to their ability to mimic the dimensions of constituent components of natural bone (e.g., proteins and hydroxyapatite), nanophase materials may be an exciting successful alternative orthopedic implant material. In this article, the ability of novel nanomaterials that promote osteointegration is discussed. Potential pitfalls or undesirable side effects associated with the use of nanomaterials in orthopedic applications are also reviewed. DOI: 10.2217/17435889.1.2.169
This article has not been linked to a wiki topic yet.
This article has not been linked to a case yet.
This article has not been linked to an atlas yet.